Breaking News Instant updates and real-time market news.

CDNA

CareDx

$39.54

0.945 (2.45%)

08:55
07/11/19
07/11
08:55
07/11/19
08:55

CareDx price target raised to $48 from $40 at Craig-Hallum

Craig-Hallum analyst Per Ostlund raised his price target for CareDx to $48 from $40 after President Trump signed an executive order to remake kidney care in the U.S., laying out a series of initiatives that clearly cement organ transplantation as a preferred treatment option for those suffering from kidney disease. While the initiatives will no doubt take some measure of time to translate into an increase in transplants, the analyst believes the order is an "unmitigated positive and wind at the back" for CareDx, which is involved in patient care across the transplant continuum. Ostlund reiterates a Buy rating on the shares.

CDNA CareDx
$39.54

0.945 (2.45%)

03/28/19
RAJA
03/28/19
NO CHANGE
RAJA
Strong Buy
CareDx lawsuit against Natera 'not unexpected,' says Raymond James
Raymond James analyst John Hsu notes that CareDx (CDNA) announced the filing of a patent infringement lawsuit against Natera (NTRA), which was "not unexpected." The analyst sees the lawsuit as consistent with management seeking to protect the company's intellectual property, and notes that the court process could take up to three years. While this lawsuit is a "logical course of action," Hsu believes CareDx remains focused on building its moat in kidney transplant, with sales force investments and a focus on integration with hospital electronic medical records. Overall, the analyst still views 2019's main focus on other activities to strengthen a "significant head start on the back of a best-in-class product launch in 2018." He reiterates a Strong Buy rating on CareDx shares.
05/09/19
PIPR
05/09/19
NO CHANGE
Target $50
PIPR
Overweight
CareDx price target raised to $50 from $42 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for CareDx to $50 from $42 following the company's better than expected Q1 results and increased outlook. CareDx has widened its "competitive moat" in transplant medicine with KidneyCare, Quirk tells investors in a research note. The stock remains his top small cap idea with an Overweight rating.
05/09/19
HCWC
05/09/19
UPGRADE
Target $43
HCWC
Buy
CareDx upgraded to Buy from Neutral at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju upgraded CareDx to Buy from Neutral and raised his price target for the shares to $43 from $30. The company in Q1 posted positive EBITDA for the third consecutive quarter, Selvaraju tells investors in a research note. The analyst believes CareDx could achieve positive EBITDA sustainably going forward.
07/10/19
RAJA
07/10/19
NO CHANGE
Target $46
RAJA
Strong Buy
CareDx should get 'Trump Bump' from kidney care speech, says Raymond James
Noting that President Donald Trump is expected to discuss policies to increase the volume of organ transplants, including kidneys by 17,000 over time, in a speech scheduled for 11 am ET this morning, Raymond James analyst John Hsu said he anticipates a positive tailwind for organ transplants and a "Trump Bump" for CareDx. While Hsu said he thinks a target to nearly double the current kidney transplant rate is "undoubtedly an ambitious goal" and he sees a 13-15% increase in year one as more likely, he raised his revenue estimates for CareDx given an expected acceleration from the 5% typical increase in annual kidney transplants. He maintains a Strong Buy rating and $46 price target on CareDx shares.

TODAY'S FREE FLY STORIES

14:32
07/16/19
07/16
14:32
07/16/19
14:32
Conference/Events
Morgan Stanley India phama analyst to hold an analyst/industry conference call »

India Pharmaceuticals…

F

Ford

$10.43

0.015 (0.14%)

, GM

General Motors

$39.21

-0.15 (-0.38%)

14:25
07/16/19
07/16
14:25
07/16/19
14:25
Periodicals
U.S. car makers open UAW contract talks as labor costs rise, WSJ reports »

Major U.S. car makers are…

F

Ford

$10.43

0.015 (0.14%)

GM

General Motors

$39.21

-0.15 (-0.38%)

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 12

    Aug

  • 23

    Oct

JBLU

JetBlue

$19.53

0.8 (4.27%)

14:25
07/16/19
07/16
14:25
07/16/19
14:25
Options
JetBlue call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

GOOG

Alphabet

$1,152.76

2.37 (0.21%)

14:25
07/16/19
07/16
14:25
07/16/19
14:25
Conference/Events
Senate Judiciary Committee to hold a hearing »

The Subcommittee on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

14:25
07/16/19
07/16
14:25
07/16/19
14:25
Conference/Events
JPMorgan SMid Cap biotech analyst to hold an analyst/industry conference call »

SMid Biotech Analyst Fye,…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
07/16/19
07/16
14:17
07/16/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/16/19
07/16
14:16
07/16/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFRX

ContraFect

$0.47

-0.0187 (-3.83%)

14:12
07/16/19
07/16
14:12
07/16/19
14:12
Conference/Events
ContraFect management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

14:10
07/16/19
07/16
14:10
07/16/19
14:10
General news
More from Kaplan: he thinks the funds rate will stabilize after just one rate cut »

More from Kaplan: he…

ATEC

Alphatec

$4.38

-0.06 (-1.35%)

14:09
07/16/19
07/16
14:09
07/16/19
14:09
Syndicate
Breaking Syndicate news story on Alphatec »

Alphatec files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 12

    Sep

SPOT

Spotify

$154.15

-0.13 (-0.08%)

, AAPL

Apple

$203.82

-1.36 (-0.66%)

14:08
07/16/19
07/16
14:08
07/16/19
14:08
Hot Stocks
Spotify slides after Apple said to plan original, exclusive podcasts »

Spotify (SPOT) shares are…

SPOT

Spotify

$154.15

-0.13 (-0.08%)

AAPL

Apple

$203.82

-1.36 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

MCD

McDonald's

$213.70

-0.48 (-0.22%)

, UBER

Uber

$44.37

-0.14 (-0.31%)

14:04
07/16/19
07/16
14:04
07/16/19
14:04
Hot Stocks
McDonald's adds DoorDash as U.S. delivery partner »

McDonald's USA and…

MCD

McDonald's

$213.70

-0.48 (-0.22%)

UBER

Uber

$44.37

-0.14 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

APRN

Blue Apron

$12.46

4.81 (62.88%)

14:00
07/16/19
07/16
14:00
07/16/19
14:00
Options
Explosive action in BlueApron as partnership with BYND anhiliates shorts »

Explosive action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

AAPL

Apple

$204.13

-1.05 (-0.51%)

, SPOT

Spotify

$154.63

0.35 (0.23%)

13:59
07/16/19
07/16
13:59
07/16/19
13:59
Periodicals
Apple to fund original podcasts in challenge to Spotify, Bloomberg says »

Apple (AAPL) plans to…

AAPL

Apple

$204.13

-1.05 (-0.51%)

SPOT

Spotify

$154.63

0.35 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

TSLA

Tesla

$252.11

-1.3 (-0.51%)

13:55
07/16/19
07/16
13:55
07/16/19
13:55
Hot Stocks
Tesla CEO Musk says cost of FSD option will increase 'every few months' »

Tesla CEO Elon Musk said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

CARS

Cars.com

$20.95

-0.56 (-2.60%)

13:55
07/16/19
07/16
13:55
07/16/19
13:55
Options
Cars.com put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.93

-0.29 (-0.99%)

, ABT

Abbott

$83.27

-0.53 (-0.63%)

13:50
07/16/19
07/16
13:50
07/16/19
13:50
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$28.93

-0.29 (-0.99%)

ABT

Abbott

$83.27

-0.53 (-0.63%)

USB

U.S. Bancorp

$53.04

-0.07 (-0.13%)

PNC

PNC Financial

$138.85

-1.33 (-0.95%)

PGR

Progressive

$84.25

0.245 (0.29%)

BK

BNY Mellon

$43.20

0.05 (0.12%)

OMC

Omnicom

$84.47

0.46 (0.55%)

TXT

Textron

$54.17

0.74 (1.39%)

CMA

Comerica

$71.70

0.34 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 26

    Aug

  • 06

    Sep

  • 16

    Oct

CSX

CSX

$79.79

1.27 (1.62%)

, CTAS

Cintas

$243.78

0.47 (0.19%)

13:49
07/16/19
07/16
13:49
07/16/19
13:49
Earnings
Notable companies reporting after market close »

Notable companies…

CSX

CSX

$79.79

1.27 (1.62%)

CTAS

Cintas

$243.78

0.47 (0.19%)

UAL

United Continental

$94.36

3.06 (3.35%)

FNF

Fidelity National

$41.43

-0.12 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 16

    Jul

  • 17

    Jul

  • 17

    Jul

  • 01

    Aug

  • 26

    Aug

  • 13

    Nov

GLYC

GlycoMimetics

$12.62

-0.17 (-1.33%)

13:45
07/16/19
07/16
13:45
07/16/19
13:45
Options
GlycoMimetics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 09

    Sep

13:35
07/16/19
07/16
13:35
07/16/19
13:35
General news
Fed funds futures are inching up from earlier lows »

Fed funds futures are…

13:35
07/16/19
07/16
13:35
07/16/19
13:35
General news
Oil Action: WTI crude »

Oil Action: WTI crude has…

FUN

Cedar Fair

$50.85

0.4 (0.79%)

13:25
07/16/19
07/16
13:25
07/16/19
13:25
Conference/Events
Cedar Fair participates in a conference call with Wedbush »

Leisure & Travel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 07

    Aug

TM

Toyota

$128.80

1.16 (0.91%)

13:20
07/16/19
07/16
13:20
07/16/19
13:20
Hot Stocks
Toyota to consider options after Hogan lawsuit verdict »

Toyota issued a statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.87

-0.12 (-0.14%)

13:20
07/16/19
07/16
13:20
07/16/19
13:20
Options
Put roll in High Yield Bond ETF re-rolls protective position »

Put roll in High Yield…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.96

-1.71 (-1.27%)

13:17
07/16/19
07/16
13:17
07/16/19
13:17
Hot Stocks
J&J falls after saying generics, biosimilars to have largest impact in Q3 »

During the company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.